Improvement of CXCR3 ligand CXCL11/I-TAC measurement in human plasma and serum

New Microbiologica

Volumn 32, Issue 1, 2009, Pages 125-128

  Cremasco, Viviana ^a   Mantelli, Barbara ^a   Lazzarin, Adriano ^a   Biswas, Priscilla ^a  

^a SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

Cell trafficking; Chemokine receptors; Chemokines; CXCL11 I TAC; CXCR3; ELISA

Indexed keywords

ANTICOAGULANT AGENT; CHEMOKINE RECEPTOR CXCR3; CXCL11 CHEMOKINE; EDETIC ACID; HEPARIN; LIGAND;

ANALYTICAL EQUIPMENT; ARTICLE; BLOOD; ENZYME LINKED IMMUNOSORBENT ASSAY; EVALUATION; HUMAN; METABOLISM;

ANTICOAGULANTS; CHEMOKINE CXCL11; EDETIC ACID; ENZYME-LINKED IMMUNOSORBENT ASSAY; HEPARIN; HUMANS; LIGANDS; REAGENT KITS, DIAGNOSTIC; RECEPTORS, CXCR3;

EID: 62149131773     PISSN: 11217138     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. BHATTACHARYYA D.K., ADAK S., BANDYO PADHYAY U., BANERJEE R.K. (1994), Mechanism of inhibition of horseradish peroxidase-catalysed iodide oxidation by EDTA. Biochem. J. 298 (Pt 2), 281-288.
2. BRAINARD D.M., TAGER A.M., MISDRAJI J., FRAHM N., LICHTERFELD M., DRAENERT R., BRANDER C., WALKER B.D., LUSTER A.D. (2007). Decreased CXCR3+ CD8 T cells in advanced human immunodeficiency virus infection suggest that a homing defect contributes to cytotoxic T-lymphocyte dysfunction. J. Virol. 81, 8439-8450.
3. CHARO I.F., RANSOHOFF R.M. (2006). The many roles of chemokines and chemokine receptors in inflammation. N. Engl. J. Med. 354, 610-621.
4. COLE K.E., STRICK C.A., PARADIS T.J., OGBORNE K.T., LOETSCHER M., GLADUE R.P., LIN W., BOYD J.G., MOSER B., WOOD D.E., SAHAGAN B.C., NEOTE K. (1998). Interferon-inducible T cell alpha chemoattractant (I-TAC): a novel non-ELR CXC chemokine with potent activity on activated T cells through selective high affinity binding to CXCR3. J. Exp. Med. 187, 2009-2021.
5. DIAMANDIS E.P. (2004). Immunoassay interference: a relatively rare but still important problem. Clin. Biochem. 37, 331-332.
6. FOLEY J.F., YU C.R., SOLOW R., YACOBUCCI M., PEDEN K.W., FARBER J.M. (2005). Roles for CXC chemokine ligands 10 and 11 in recruiting CD4+ T cells to dendritic cells, and lymph nodes. J. Immunol. 174, 4892-4900.
7. HASSON H., MANTELLI B., BISWAS P., MALNATI M., GIANOTTI N., VECCHI A., NOZZA S., CERNUSCHI M., BOERI E., CLERICI M., LAZZARIN A., BERETTA A. (2007). Favorable outcome of ex-vivo purging of monocytes after the reintroduction of treatment after interruption in patients infected with multidrug resistant HIV-1.7. Med. Virol. 79, 1640-1649.
8. LIU L., CALLAHAN M.K., HUANG D., RANSOHOFF R.M. (2005). Chemokine receptor CXCR3: an unexpected enigma. Curr. Top. Dev. Biol. 68, 149-181.
9. PEKAREK V., SRINIVAS S., ESKDALE J., GALLAGHER G. (2007). Interferon lambda-1 (IFN-lambdal/IL-29) induces ELR(-) CXC chemokine mRNA in human peripheral blood mononuclear cells, in an IFN-gamma-independent manner. Genes. Immun. 8, 177-180.
10. RANJBARAN H., WANG Y., MANES T.D., YAKIMOV A.O., AKHTAR S., KLUGER M.S., POBER J.S., TELLIDES G. (2006). Heparin displaces interferon-gamma-inducible chemokines (IP-10, I-TAC, and Mig) sequestered in the vasculature and inhibits the transendothelial migration and arterial recruitment of T cells. Circulation. 114, 1293-1300.
11. SAUTY A., COLVIN R.A., WAGNER L., ROCHAT S., SPERTINI F., LUSTER A.D. (2001). CXCR3 internalization following T cell-endothelial cell contact: preferential role of IFN-inducible T cell alpha chemoattractant (CXCL11). J. Immunoll. 167, 7084-7093.
12. TENSEN C.P., FLIER J., RAMPERSAD S.S., SAMPAT-SARDJOEPERSAD S., SCHEPER R.J., BOORSMA D.M., WILLEMZE R. (1999). Genomic organization, sequence and transcriptional regulation of the human CXCL 11(1) gene. Biochim. Biophys. Acta. 1446, 167-172.